This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Observational studies and randomised controlled trials (RCTs) have yielded conflicting results regarding the outcomes of multiple arterialgrafts (MAG) vs. single arterialgrafts (SAG) in coronaryarterybypassgraft (CABG) surgery. The follow-up period ranged from 6 months to 12.6
Both indexes have been extensively validated in clinical trials in guiding revascularisation in patients with stable ischaemic heart disease undergoing percutaneous coronary intervention (PCI) with improved clinical outcomes. However, the role of these tools in coronaryarterybypassgrafting (CABG) is less clear.
In this setting, implantation of a durable left ventricular assist device (LVAD) might be an alternative.MethodsWe retrospectively compared the outcomes of adult patients with CAD and a left ventricular ejection fraction (LVEF) ≤ 25% who underwent coronaryarterybypassgrafting (CABG) vs. LVAD implantation.
IPTW-adjusted Kaplan–Meier estimates by study group were calculated for all-cause mortality, stroke, the risk of repeat revascularization and myocardialinfarction up to a maximum follow-up of 10 years. In the FS group, the freedom from stroke at 1, 5, and 10 years was 97.0%, 93.0%, and 93.0%, respectively. units ± 1.83
Self-reported smoking status was assessed at each consecutive visit and used to determine smoking cessation after each interim ASCVD event (myocardialinfarction, percutaneous coronary intervention, coronaryarterybypassgraft, stroke/transient ischemic attack, peripheral artery disease).
Hospital mortality was 17% ( n = 192), postoperative stroke or TIA occurred in 5.2% ( n = 58), and postoperative dialysis was required in 11% ( n = 109) of patients. 4.65, P < 0.001), recent myocardialinfarction (OR: 6.42, CI: 2.24–18.41, 4.65, P < 0.001), recent myocardialinfarction (OR: 6.42, CI: 2.24–18.41,
The primary outcome was risk of an ASCVD hospitalization composite outcome (myocardialinfarction, coronaryarterybypassgraft, percutaneous coronary intervention, stroke, transient ischemic accident) after COPD hospitalization relative to before COPD hospitalization.
BACKGROUND:Diabetes may be associated with differential outcomes in patients undergoing left main coronary revascularization with percutaneous coronary intervention (PCI) or coronaryarterybypassgrafting (CABG). 1.52]) or without (155/1634 [9.7%] versus 142/1655 [8.9%]; hazard ratio, 1.08 [95% CI, 0.86–1.36;PintHR=0.87)
Left main coronaryartery disease (CAD) and diabetes pose significant challenges in cardiovascular care, often leading to adverse outcomes. However, the comparative long-term efficacy of percutaneous coronary intervention (PCI) versus coronaryarterybypassgrafting (CABG) in patients with these conditions remains unclear.
The outcomes of interest were all-cause death and major adverse cardiovascular events (MACE), including acute coronary syndrome (ACS), heart failure (HF), need for additional revascularization, target vessel revascularization (TVR), SCAD recurrence, and stroke. The overall mean age was 49.12 +/− 3.41, and 88% were females.
Background New-onset postoperative atrial fibrillation (POAF) after coronaryarterybypassgrafting (CABG) increases ischaemic stroke risk, yet factors influencing this risk remain unclear. OAC dispensing patterns were described based on stroke-associated factors. Out of those not receiving OAC (n=6903), 3.1%
This study investigates the relationship between baseline 5-HTP levels and the incidence of major adverse cardiovascular events (MACE) in patients who have experienced ST-elevation myocardialinfarction (STEMI).Objective:Our years, 53 women) followed for up to 15 years.
We have studied whether NCA is also a predictor of poorer outcomes in patients undergoing coronaryarterybypassgrafting (CABG). The primary outcome was a combination of TIA/stroke, acute myocardialinfarction, new revascularization procedure, or death.
Cox proportional hazard regression was used to evaluate the effect of Lp(a) on AVR, AVR or cardiac death, and valvular or cardiovascular events (AVR, cardiac death, myocardialinfarction, stroke, heart failure, or coronaryarterybypassgrafting). The maximal followup time was set to 5 years.
Findings from this study revealed that higher stress levels were linked to an increased risk of CVD and stroke, after taking into account sociodemographic factors and health risk behaviors. In addition, the risks increased with increasing stress levels for death and coronary heart disease.
Adult Cardiac Surgery Database Lead Author Title Publication Date Jacob Raphael Red Blood Cell Transfusion and Pulmonary Complications: The Society of Thoracic Surgeons Adult Cardiac Surgery Database Analysis The Annals of Thoracic Surgery January 2024 Joseph Sabik Multi-Arterial versus Single-ArterialCoronary Surgery: Ten Year Follow-up of One Million (..)
Program Designations Access and Publications (A&P) 1 Participant User File (PUF) 2 Task Force on Funded Research (TFR) 3 Special Projects 4 Adult Cardiac Surgery Database Lead Author Title Publication Date William Keeling 2 National Trends in Emergency CoronaryArteryBypassGrafting European Journal of Cardiothoracic Surgery October 2023 Jake (..)
Due to the limited number of ischemic stroke and cardiac arrest cases among AAS users, these outcomes were not reportable.CONCLUSIONS:AAS use is associated with a substantially increased risk of cardiovascular disease in a large cohort with a long follow-up period.
Introduction Matrix metalloproteinases (MMPs) and tissue inhibitors of metalloproteinases (TIMPs) have been linked to clinical outcomes in patients with coronaryartery disease (CAD). However, the prognostic value of TIMP-1 in patients with CAD who underwent coronaryarterybypassgrafting (CABG) has not been elucidated.
The primary endpoint was MACEs, which represented a composite event of all-cause death, stroke, systemic embolism, and massive hemorrhage.Results:The 2,182 patients were divided into two groups: LVEDD>60mm group (n=370) and LVEDD ≤60 mm group (n=1812). vs. 26.0%), Compared with the LVEDD ≤60 mm group.
Primary endpoints included overall mortality, cardiac-related mortality, stroke, myocardialinfarction, repeat revascularization. The piggyback anastomosis consisted of vein-on-vein (52.7%, 59/112), artery-on-vein (43.8%, 49/112), and double vein/artery configurations (3.6%, 4/112). The mean hospital stay was 5.5
We organize all of the trending information in your field so you don't have to. Join thousands of users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content